Constipation in children is a common, vexing problem for the patient, his or her parents, and the pediatric gastroenterologist. Most cases have no discernible organic cause. Evidence indicates that endogenous C24 dihydroxy- bile acids (chenodeoxycholic and/or deoxycholic acid) act as natural cathartics by inducing colonic secretion and colonic propulsion. Our hypothesis is that some cases of childhood constipation are caused by defects in bile acid biosynthesis resulting in a decreased colonic concentration of C24 dihydroxy bile acids. Possible defects include defective hydroxylation of the steroid nucleus (defective sterol 12 hydroxylase (cyp8B1) or defective side chain oxidation (defects in peroxisomal enzymes). To test this hypothesis, fecal samples will be obtained from children with chronic constipation as well as from children without constipation. Samples will be analyzed by electrospray mass spectrometry (ESI-MS) and by gas chromatography mass spectrometry (GC-MS). ESI-MS provides information on side chain biotransformations involved in oxidation of the C8 cholesterol side chain to the C5 side chain present in C24 bile acids. GC-MS provides information on the efficiency of C-12 hydroxylation. Patients with defects in side chain oxidation or C-12-hydroxylation will receive genetic analysis by collaborators. If successful, this project will show that some cases of constipation are caused by defective bile acid biosynthesis.Preliminary results have identified children with increased C27 bile acids suggesting defects in peroxisomal enzymes. Results of this study should lead to clinical trials that test the efficacy of oral primary bile acids for constipation caused by defective bile acid biosynthesis.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Small Research Grants (R03)
Project #
5R03DK064891-02
Application #
6931906
Study Section
Special Emphasis Panel (ZDK1-GRB-9 (J1))
Program Officer
Robuck, Patricia R
Project Start
2004-08-15
Project End
2008-07-31
Budget Start
2005-08-01
Budget End
2008-07-31
Support Year
2
Fiscal Year
2005
Total Cost
$152,000
Indirect Cost
Name
University of California San Diego
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
804355790
City
La Jolla
State
CA
Country
United States
Zip Code
92093
Hagey, Lee R; Vidal, Nicolas; Hofmann, Alan F et al. (2010) Evolutionary diversity of bile salts in reptiles and mammals, including analysis of ancient human and extinct giant ground sloth coprolites. BMC Evol Biol 10:133
Hagey, Lee R; Møller, Peter R; Hofmann, Alan F et al. (2010) Diversity of bile salts in fish and amphibians: evolution of a complex biochemical pathway. Physiol Biochem Zool 83:308-21
Keating, Niamh; Mroz, Magdalena S; Scharl, Michael M et al. (2009) Physiological concentrations of bile acids down-regulate agonist induced secretion in colonic epithelial cells. J Cell Mol Med 13:2293-303
Halilbasic, Emina; Fiorotto, Romina; Fickert, Peter et al. (2009) Side chain structure determines unique physiologic and therapeutic properties of norursodeoxycholic acid in Mdr2-/- mice. Hepatology 49:1972-81
Kakiyama, Genta; Tamegai, Hideyuki; Iida, Takashi et al. (2007) Isolation and chemical synthesis of a major, novel biliary bile acid in the common wombat (Vombatus ursinus): 15alpha-hydroxylithocholic acid. J Lipid Res 48:2682-92
Gass, Jonathan; Vora, Harmit; Hofmann, Alan F et al. (2007) Enhancement of dietary protein digestion by conjugated bile acids. Gastroenterology 133:16-23
Keely, Stephen J; Scharl, Michael M; Bertelsen, Lone S et al. (2007) Bile acid-induced secretion in polarized monolayers of T84 colonic epithelial cells: Structure-activity relationships. Am J Physiol Gastrointest Liver Physiol 292:G290-7
Hamilton, James P; Xie, Guofeng; Raufman, Jean-Pierre et al. (2007) Human cecal bile acids: concentration and spectrum. Am J Physiol Gastrointest Liver Physiol 293:G256-63
Fickert, Peter; Wagner, Martin; Marschall, Hanns-Ulrich et al. (2006) 24-norUrsodeoxycholic acid is superior to ursodeoxycholic acid in the treatment of sclerosing cholangitis in Mdr2 (Abcb4) knockout mice. Gastroenterology 130:465-81
Rius, Maria; Hummel-Eisenbeiss, Johanna; Hofmann, Alan F et al. (2006) Substrate specificity of human ABCC4 (MRP4)-mediated cotransport of bile acids and reduced glutathione. Am J Physiol Gastrointest Liver Physiol 290:G640-9

Showing the most recent 10 out of 17 publications